Medical News & Physician Commentary
November 17, 2016 – KENILWORTH, N.J.–(BUSINESS WIRE)–The Merck Foundation (Foundation) announced today the launch of a new initiative, Bridging the Gap: Reducing Disparities in Diabetes Care (Bridging the Gap), to improve access to high-quality diabetes care and reduce health disparities for vulnerable and underserved populations in the United States. With $10 million in funding from the […]
GSK announces new data from phase III studies of sirukumab in adult patients with moderately to severely active rheumatoid arthritis
London – 16 November 2016 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced results from two pivotal phase III studies evaluating subcutaneous sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody in development for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). The first study (SIRROUND-T), in patients who were refractory to or intolerant to […]
Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations
FOSTER CITY, Calif.–(BUSINESS WIRE)–Nov. 16, 2016– Gilead Sciences, Inc. (NASDAQ: GILD) today announced the promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations, with responsibility for commercial operations in North America, Europe and Japan. Mr. Meyers will become an officer of the company and member of Gilead’s senior leadership team. Mr. Meyers […]
Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers
Cooperative Research and Development Agreement (CRADA) assesses OX40 agonist, utomilumab and avelumab immuno-oncology assets alone and in various combinations November 14, 2016 – Pfizer Inc. (NYSE:PFE) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). As part […]
January 19, 2017 @ 9:00 am – January 21, 2017 @ 5:00 pm
The Gastrointestinal (GI) Cancers Symposium is a specialized oncology event designed to provide scientific and educational content for members of the GI cancer care and research community.
February 17, 2017 @ 9:00 am – February 19, 2017 @ 5:00 pm
The AAAS Annual Meeting is interdisciplinary and inclusive. Each year, our community gathers together to discuss recent developments in science and technology. Below you’ll find stories from many of our attendees.
February 19, 2017 @ 9:00 am – February 24, 2017 @ 5:00 pm
Attracting over 3,500 drug discovery and development professionals from over 40 countries in 2016, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
February 19, 2017 @ 9:00 am – February 23, 2017 @ 5:00 pm
The 2017 HIMSS Annual Conference & Exhibition, February 19–23, 2017 in Orlando, brings together 40,000+ health IT professionals, clinicians, executives and vendors from around the world. Exceptional education, world-class speakers, cutting-edge health IT products and powerful networking are hallmarks of this industry-leading conference.